Хайлтын үр дүнгүүд - George D. Demetri
- 128-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
Advances in the treatment of gastrointestinal stromal tumours -н Ian Judson, George D. Demetri
Хэвлэсэн 2007Revisão -
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Isolation and chromosomal localization of cDNAs encoding a novel human lymphocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human a... -н Thomas F. Tedder, Cary Isaacs, T J Ernst, George D. Demetri, David A. Adler, Christine M. Distèche
Хэвлэсэн 1989Artigo -
13
-
14
-
15
-
16
A Preeclampsia-like Syndrome Characterized by Reversible Hypertension and Proteinuria Induced by the Multitargeted Kinase Inhibitors Sunitinib and Sorafenib -н T. V. Patel, Jeffrey A. Morgan, George D. Demetri, Suzanne George, Robert G. Maki, Michael Quigley, Benjamin D. Humphreys
Хэвлэсэн 2008Carta -
17
-
18
Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors -н George D. Demetri, Yanfeng Wang, Elisabeth Wehrle, Amy Racine, Zariana Nikolova, Charles D. Blanke, Heikki Joensuu, Margaret von Mehren
Хэвлэсэн 2009Artigo -
19
Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma -н George D. Demetri, Christopher D.�M. Fletcher, Elisabetta Mueller, Pasha Sarraf, Ryan Naujoks, Natalee Campbell, Bruce M. Spiegelman, Samuel Singer
Хэвлэсэн 1999Artigo -
20
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Oncology
Cancer
Pathology
Stromal cell
Cancer research
Biology
Surgery
GiST
Imatinib
Myeloid leukemia
Chemotherapy
Sarcoma
Clinical trial
Gastroenterology
Genetics
Sunitinib
Gene
Imatinib mesylate
Soft tissue sarcoma
Adverse effect
Soft tissue
Receptor
Clinical endpoint
Phases of clinical research
Tyrosine-kinase inhibitor
Cell biology
Stromal tumor
Biochemistry